The tests will begin to ship next week with plans of using the product by the end of the month
“During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities,” Dr. David Persing, Cheif Medical and Technology Officer at Cepheid, said.
Cepheid will use its GeneXpert System to run the tests, of which there are more than 23,000 worldwide and 5,000 in the United States, the release noted. The GeneXpert Systems “do not require users to have specialty training to perform testing,” Cepheid President Warren Kocmond added., the tests will begin to ship next week with plans of using the product by the end of the month.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA approves new test that could detect coronavirus in about 45 minutesThe FDA announced its approval of the use of the first rapid diagnostic test that could detect coronavirus in approximately 45 minutes. Authorization was made Friday and tests will begin shipping next week, according to the company manufacturing the tests
続きを読む »
FDA cracks down on fake coronavirus tests, preventions and treatmentsThe US Food and Drug Administration said it is closely watching the market and will take appropriate action against firms offering fraudulent coronavirus tests, preventions and treatments
続きを読む »
FDA says it won't take action against manufacturers that start making hand sanitizerThe federal government will allow firms to begin manufacturing their own hand sanitizer with limited guidance as the spreading coronavirus dwindles supply across the country.
続きを読む »